Back to CVE records
Low 2.1Published Sep 1, 2026

CVE-2026-82740Ash.Type ignores outer array constraints on nested {:array, {:array, type}} inputs

Updated under an hour ago ()

Does this affect you?

It affects ash-project ash. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Improper Input Validation vulnerability in ash-project ash fails to enforce the outer array constraints on a doubly-nested {:array, {:array, type}} attribute, letting invalid input pass validation. Ash.Type.apply_constraints/3 (lib/ash/type/type.ex) handled the {:array, {:array, type}} case by mapping only the inner {:array, type} constraints over each element, so constraints declared on the outer array (such as min_length, max_length, and nil_items?) were never applied. An attacker could submit an outer list that violates those constraints (too many elements, or nil entries where disallowed) and have it accepted and persisted. The fix enforces the outer array constraints and adds explicit handling for nil and non-list inputs. This issue affects ash: from 2.16.1 before 3.32.2.

CVSS
2.1 LOW (v4.0, CNA)CVSS:4.0/AV:L/AC:L/AT:P/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N
Weakness (CWE)
CWE-20
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
EEF
NVD analysis
Deferred
Record last updated
Sep 1, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
ash-project ash
ash-project:ash
from 2.16.1 before 3.32.2
CNA record

References

  • vendor-advisory, related
  • related
  • related
  • patch

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.